연구

연구업적

최근 5년 연구업적 현황
연도 2024년 2023년 2022년 2021년 2020년
SCI 논문
발표편수
책임 179편 173편 163편 184편 135편
공동 147편 120편 115편 136편 168편
합계 326편 293편 278편 320편 303편
2787. Augmentation of the RNA m6A reader signature is associated with poor survival by enhancing cell proliferation and EMT across cancer type
Jaeik Oh, Chanwoong Hwa, Dongjun Jang, Seungjae Shin, Soo-Jin Lee, Jiwon Kim, Sang Eun Lee, Hae Rim Jung, Yumi Oh, Giyong Jang, Obin Kwon, Joon-Yong An, Sung-Yup Cho
Exp Mol Med. 2022 Jul;54(7):906-921 Link
2786. Comparative analysis of cancer gene mutations using targeted sequencing in matched primary and recurrent gastric cancers after chemotherapy
Yeon-Ju Huh, Sung-Yup Cho, Min-Sun Cho, Kyoung-Eun Lee, Joo-Ho Lee
Genes Genomics. 2022 Nov;44(11):1425-1435 Link
2785. Anti-C4d chimeric antigen receptor regulatory T cells suppressed allograft rejection in ABO-incompatible heart transplantation
Lee SK, Han J, Piao H, Shin N, Jang JY, Yan JJ, Kim H, Chung J, Yang J
Genes Dis. 2022 Jan;9(1):1-4 Link
2784. Optimization of peripheral blood volume for in silico reconstitution of the human B-cell receptor repertoire.
Lee H, Yoo DK, Han J, Kim KH, Noh J, Lee Y, Lee E, Kwon S, Chung J.
FEBS Open Bio. 2022 Sep;12(9):1634-1643 Link
2783. Clinicopathologic and Genetic Features of Primary T-cell Lymphomas of the Central Nervous System: An Analysis of 11 Cases Using Targeted Gene Sequencing
Jeemin Yim 1, Jiwon Koh 1 2, Sehui Kim 1 3, Seung Geun Song 1, Jeong Mo Bae 1 2, Hongseok Yun 2, Ji-Youn Sung 4, Tae Min Kim 5 6, Sung-Hye Park 1, Yoon Kyung Jeon 1 6
Am J Surg Pathol. 2022 Apr 1;46(4):486-497. Link
2782. ALK Translocation in ALK-Positive Mesenchymal Tumors: Diagnostic and Therapeutic Insights
Minsun Jung 1 2, Kyung Chul Moon 1 3, Jeongmo Bae 1, Tae Min Kim 4 5, Miso Kim 4 5, Yoon Kyung Jeon 1 5, Cheol Lee 1
Arch Pathol Lab Med. 2022 Dec 1;146(12):1460-1470. Link
2781. Pediatric-Type Indolent B-Cell Lymphomas With Overlapping Clinical, Pathologic, and Genetic Features
Sojung Lim 1, Ka Young Lim 1, Jiwon Koh 1, Jeong Mo Bae 1, Hongseok Yun 2, Cheol Lee 1, Young A Kim 3, Jin Ho Paik 4, Yoon Kyung Jeon 1 5
Am J Surg Pathol. 2022 Oct 1;46(10):1397-1406 Link
2780. TCF1+PD-1+ tumour-infiltrating lymphocytes predict a favorable response and prolonged survival after immune checkpoint inhibitor therapy for non-small-cell lung cancer
Jaemoon Koh 1, Sehui Kim 2, Yeon Duk Woo 3, Seung Geun Song 1, Jeemin Yim 4, Bogyeong Han 4, Sojung Lim 4, Hyun Kyung Ahn 5, Seungchan Mun 6, Jung Sun Kim 7, Bhumsuk Keam 7, Young A Kim 8, Se-Hoon Lee 9, Yoon Kyung Jeon 10, Doo Hyun Chung 11
Eur J Cancer. 2022 Oct;174:10-20. Link
2779. Molecular Classification of Extrapulmonary Neuroendocrine Carcinomas With Emphasis on POU2F3-positive Tuft Cell Carcinoma
Jiwon Koh 1, Haeryoung Kim 1, Kyung Chul Moon 1, Cheol Lee 1, Kyoungbun Lee 1, Han Suk Ryu 1, Kyeong Cheon Jung 1, Yoon Kyung Jeon 1 2
Am J Surg Pathol. 2022 Oct 14. Link
2778. High tumor hexokinase-2 expression promotes a pro-tumorigenic immune microenvironment by modulating CD8+/regulatory T-cell infiltration
Sehui Kim 1 2, Jaemoon Koh 1, Seung Geun Song 1 3, Jeemin Yim 1, Miso Kim 4, Bhumsuk Keam 4, Young Tae Kim 5 6, Jihun Kim 7, Doo Hyun Chung 1 3, Yoon Kyung Jeon 8 9
BMC Cancer. 2022 Nov 1;22(1):1120 Link